David M Mott Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 3 days, 20 hours ago
David M Mott has an estimated net worth of at least $11.3 million*, as of April 15, 2026. They own 3.3 million shares of ARDX stock. They have sold 24,961 shares of ARDX stock since 2021, for an estimated $-9.7 million.
David M Mott $ARDX SEC Form 4 Insider Trading
David M Mott has filed a total of 10 insider trades in $ARDX since 2021. Their most recent trade was a purchase of 333,333 shares, made on Feb 20, 2026. Their largest trade was a purchase of 567,000 shares, made on Nov 17, 2022. We estimate that they now own 3.3 million shares of $ARDX, worth an estimated $21.0 million.
Insider Trading at $ARDX
There have been a total of 305 insider trades reported at $ARDX since 2021, with 2.5 million shares purchased and 9.5 million shares sold. The most active insider traders in $ARDX stock have been David P. Rosenbaum, Michael Raab, and Elizabeth A Grammer. The most recent trade was a sale of 41,668 shares reported by MICHAEL RAAB (President & CEO), made on Apr 15, 2026.
History of Insider Stock Trades by David M Mott
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
ARDX
|
Purchase | 333,333 | Feb 20, 2026 | Feb. 23, 2026, 10:01 p.m. |
|
ARDX
|
Purchase | 200,000 | Jun 16, 2025 | June 18, 2025, 9:28 p.m. |
|
ARDX
|
Purchase | 200,000 | Jun 09, 2025 | June 11, 2025, 9:40 p.m. |
|
ARDX
|
Purchase | 100,000 | May 15, 2025 | May 19, 2025, 5:02 p.m. |
|
ARDX
|
Purchase | 381,377 | May 02, 2025 | May 5, 2025, 8:22 p.m. |
|
ARDX
|
Purchase | 77,729 | Feb 24, 2025 | Feb. 26, 2025, 8:21 p.m. |
|
ARDX
|
Purchase | 199,000 | Jan 21, 2025 | Jan. 22, 2025, 6:25 p.m. |
|
ARDX
|
Purchase | 213,300 | Dec 19, 2024 | Dec. 23, 2024, 6:59 p.m. |
|
ARDX
|
Purchase | 215,868 | Nov 13, 2024 | Nov. 14, 2024, 5:26 p.m. |
|
ARDX
|
Purchase | 567,000 | Nov 17, 2022 | Nov. 17, 2022, 5:07 p.m. |
IMRA
|
Purchase | 35,257 | Feb 23, 2022 | Feb. 23, 2022, 8:12 p.m. |
|
IMRA
|
Purchase | 50,398 | Feb 18, 2022 | Feb. 23, 2022, 8:12 p.m. |
|
IMRA
|
Purchase | 65,817 | Feb 22, 2022 | Feb. 23, 2022, 8:12 p.m. |
|
IMRA
|
Purchase | 14,595 | Feb 17, 2022 | Feb. 17, 2022, 8:21 p.m. |
|
IMRA
|
Purchase | 19,552 | Feb 15, 2022 | Feb. 17, 2022, 8:21 p.m. |
|
IMRA
|
Purchase | 11,779 | Feb 16, 2022 | Feb. 17, 2022, 8:21 p.m. |
|
IMRA
|
Purchase | 8,500 | Feb 14, 2022 | Feb. 14, 2022, 6:02 p.m. |
|
IMRA
|
Purchase | 8,753 | Feb 10, 2022 | Feb. 14, 2022, 6:02 p.m. |
|
IMRA
|
Purchase | 14,573 | Feb 11, 2022 | Feb. 14, 2022, 6:02 p.m. |
NVAX
|
Sale | 5,728 | Sep 23, 2021 | Sept. 23, 2021, 8 p.m. |
|
NVAX
|
Sale | 7,744 | Sep 23, 2021 | Sept. 23, 2021, 8 p.m. |
|
NVAX
|
Sale | 2,732 | Sep 23, 2021 | Sept. 23, 2021, 8 p.m. |
|
NVAX
|
Sale | 1,200 | Sep 23, 2021 | Sept. 23, 2021, 8 p.m. |
|
NVAX
|
Sale | 7,557 | Sep 23, 2021 | Sept. 23, 2021, 8 p.m. |
$ARDX Executives and Stock Owners with Insider Trades
-
David P. Rosenbaum, Chief Development Officer
-
Michael Raab, President & CEO
-
Elizabeth A Grammer, See Remarks
-
Justin A Renz, Chief Financial Officer
-
Robert Blanks, See Remarks
-
Laura A Williams, Chief Medical Officer
-
Susan Rodriguez, Chief Commercial Officer
-
Robert Ora Felsch, See Remarks
-
Eric Duane Foster, Chief Commercial Officer
-
Jeffrey W Jacobs, Chief Scientific Officer
-
Mike Kelliher, See Remarks
-
Laura A Williams, Chief Patient Officer
-
Joseph James Reilly, See Remarks
-
John E Bishop, See Remarks
-
Laura A Williams, See Remarks
-
James Parker Brady, Chief Human Resources Officer
-
Susan Hohenleitner, Chief Financial Officer
-
Mike Kelliher, Chief Business Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.